Health Research Alliance
2017 Lab Invest (Watanabe).pdf (404.31 kB)
Download file

A pathologist’s perspective on induced pluripotent stem cells

Download (404.31 kB)
journal contribution
posted on 2019-03-05, 17:13 authored by Naohiro Terada, Noriko Watanabe, Katherine E. Santostefano, Anthony T. Yachnis
Induced pluripotent stem cell (iPSC) technology was originally developed in 2006. Essentially, it converts somatic cells into pluripotent stem cells by transiently expressing a few transcriptional factors. Once generated, these iPSCs can differentiate into all the cell types of our body, theoretically, which has attracted great attention for clinical research including disease pathobiology studies. Could this technology then become an additional research or diagnostic tool widely available to practicing pathologists? Here we summarize progress in iPSC research toward disease pathobiology studies, its future potential, and remaining problems from a pathologist’s perspective. A particular focus will be on introducing the effort to recapitulate disease-related morphological changes through three-dimensional culture of stem cells such as organoid differentiation.


Grant ID

American Heart Association (16GRNT30980002)

Usage metrics